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EIA is a retroviral disease affecting all equidae and its diagnosis is
principally based on the use of serological methods represented
by agar gel immunodiffusion test (AGIDT), ELISA and the
immunoblot that are used on the basis of the intended purpose.
OIE proposes both AGIDT and ELISA as suitable for the demon-
stration of individual or population freedom from infection.
Important characteristic for a serological method to be used asscreening test in a control programme is its sensitivity that as-
sures the detection of the highest possible number of cases.
Relative to this are different studies reporting on the higher
sensitivity of the ELISA compared to the AGIDT (1, 2). As Italy,
like in many other countries, has a regulatory control program
for EIA, the National Reference Centre for EIA (NRCEIA) con-
ducted a study in which the diagnostic performance of all ELISA
serological kits available in the country, as candidate/s for a
screening test, was evaluated. Ten ofﬁcial laboratories partici-
pated in the study where each examined a sample panel con-
taining negative and positive sera with different levels of
positivity, using four commercial and 2 in-house kits. The same
kits were also assessed for their precocity by the NRCEIA using a
panel of sera from vaccinated animals at different days post-
vaccination. All the serum samples used in this study were also
tested in AGIDT. The parameters evaluated were: diagnostic
sensitivity (DSe) and speciﬁcity (DSp), Cohen K, weighted Cohen
K, coefﬁcient of variation (CV), accordance and concordance. The
results obtained were the following; Dse and DSP for all kits
were 100% deﬁning, all tests as accurate. K multiple was equal to
0.76 while the value of K for all laboratories, compared with each
other was 0.72. The K values indicate a degree of concordance
almost perfect according to the classiﬁcation of Landis et. al. (3).
The CV values obtained for all sera were less than 20%, and for
this repeatability and the reproducibility for the kits evaluated
was satisfactory. Moreover, accordance and concordance were
close to 100% in more than half of the sera. Analysis of these
parameters show that all kits employed have a high diagnostic
performance and also a higher sensitivity than AGID in terms of
analytical sensitivity and precocity. Even if a complete evalua-
tion, according to the OIE standards, is required, all kits resulted
suitable candidates as screening tools capable of increasing the
efﬁcacy of EIA control programmes.References
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